Silji Abraham - 08 Aug 2023 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
SVP, Chief Technology Officer
Signature
Ryan Metz, as agent for Silji Abraham
Issuer symbol
WST
Transactions as of
08 Aug 2023
Net transactions value
-$3,240,972
Form type
4
Filing time
10 Aug 2023, 16:31:00 UTC
Previous filing
02 May 2023
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $836,482 +8,160 +194% $102.51 12,369 08 Aug 2023 Direct
transaction WST Common Stock Sale $3,238,586 -8,154 -66% $397.18 4,215 08 Aug 2023 Direct F1
transaction WST Common Stock Sale $2,386 -6 -0.14% $397.69 4,209 08 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Options (Right to buy) Options Exercise $836,482 -8,160 -100% $102.51 0 08 Aug 2023 Common Stock 8,160 $102.51 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $396.53 to $397.285, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F2 This option is fully vested.